百诚医药:公司已获得1个1类创新药 10个2类创新药的临床试验批准

美港电讯
15 Apr

【百诚医药:公司已获得1个1类创新药 10个2类创新药的临床试验批准】金十数据4月15日讯,百诚医药在互动平台表示,公司开展了多个新药研发项目,截至目前,公司已获得1个1类创新药,10个2类创新药的临床试验批准。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10